LETTER OF TRANSMITTALCongress of the United StatesOffice of Technology AssessmentWashington, D.C., July 15, 1974
Harrison A. Williams
Harley O. StaggersChairman,Senate Committee onChairman, House Committee onLabor & Public WelfareInterstate & Foreign CommerceUnited States SenateU. S. House of RepresentativesWashington, D.C.
On behalf of the Board of the Office of TechnologyAssessment, we are pleased to forward to you thefollowing report of the Drug Bioequivalence Study Panel,which was assembled on April 12, 1974, under the chairman-
ship of Dr.
Robert Berliner.The Panel was asked to deter-
mine whether or not the technological capability is now
available to assure that drug products with the samephysical and chemical composition will produce com-parable therapeutic effects.This report is being made available to yourCommittees in accordance with Public Law 92-484, withappreciation and thanks to Dr. Berliner and his
colleagues on the OTA Drug Bioequivalence Study Pane}. “
Respectfully yours,Edward M. Kennedy